Certolizumab pegol

Therapeutic Certolizumab pegol ADC from the original Cimzia® commercial drug.

Reference Standard as Aliquots

Cimzia®
Filters Sort results
Reset Apply
Product Batch
Therapeutic Expiry Date
Brand & Origin
Amount per Aliquot
Select Quantity
Discount
Price per Aliquot
2022.09
Cimzia®
DE
8 mg
Max: 9
Min: 2
Step: 1
Unit: aliquot(s)
274,00  /aliquot
2025.03
Cimzia®
DE
8 mg
Max: 10
Min: 2
Step: 1
Unit: aliquot(s)
274,00  /aliquot

Biosimilars as Aliquots​

Filters Sort results
Reset Apply
No results found. Clear filters and try again?

Access Batch Specific Analytical Information

Evidentic’s Analytical Data Service includes a comprehensive array of methods to support the drug development process, including structure, aggregation, degree of isomerization, and N-glycans identification of the active pharmaceutical ingredient (API). ​

Request an Offer​

and Download a Sample Report​

1. Choose your method(s) of interest
2. Provide your contact details
3. Send us your request and receive a downloadable sample report


Please provide your contact information


send us your inquiry and download a free sample file


Product Information

Here you will find the product information for the reference product.

Cimzia® / Certolizumab Pegol Reference Product

Drug nameCimzia®
INNCertolizumab Pegol
API typeCertolizumab pegol is a recombinant, humanised antibody Fab' fragment (ADC) against tumour necrosis
factor alpha (TNFα) expressed in Escherichia coli and conjugated to polyethylene glycol (PEG).
Pharmacotherapeutic group
Immunosuppressants, Tumour Necrosis Factor alpha (TNF-α) inhibitors.
ATC code
L04AB05
Target of antibody
TNF alpha
General functionCertolizumab Pegol, in combination with methotrexate (MTX), is indicated for the treatment of moderate to severe, active rheumatoid arthritis (RA) in adult patients when the response to disease-modifying antirheumatic drugs (DMARDs) including MTX, has been inadequate. Cimzia can be given as monotherapy in case of intolerance to MTX or when continued treatment with MTX is inappropriate. is also indicated for the treatment of severe, active and progressive RA in adults not previously treated with MTX or other DMARDs.
Short description
Pharmacodynamic properties
(Mechanism of action; Source EMA document)
Certolizumab Pegol has a high affinity for human TNFα and binds with a dissociation constant (KD) of 90 pM.
TNFα is a key pro-inflammatory cytokine with a central role in inflammatory processes. Certolizumab Pegol selectively neutralises TNFα (IC90 of 4 ng/ml for inhibition of human TNFα in the in vitro L929 murine fibrosarcoma cytotoxicity assay) but does not neutralise lymphotoxin α (TNFβ). Certolizumab Pegol was shown to neutralise membrane associated and soluble human TNFα in a dose-dependent manner. Incubation of monocytes with Cimzia resulted in a dose-dependent inhibition of lipopolysaccharide (LPS)-induced TNFα and IL1β production in human monocytes.
Pharmacodynamic properties (Pharmacodynamic effects; Source EMA document)Certolizumab Pegol does not contain a fragment crystallisable (Fc) region, which is normally present in a complete antibody and therefore does not fix complement or cause antibody-dependent cell-mediated cytotoxicity in vitro. It does not induce apoptosis in vitro in human peripheral blood-derived monocytes or lymphocytes, or neutrophil degranulation.
Original license holder
UCB Pharma S.A.
Allée de la Recherche 60
B-1070 Bruxelles
Belgium
Marketing authorisation numbers
EU/1/09/544/004
Marketing authorisation holder
UCB Pharma S.A.
Allée de la Recherche 60
B-1070 Bruxelles
Belgium
Name of the manufacturer of the biological active substance
UCB Farchim SA
Zone Industrielle de Planchy d’Avau
Chemin de Croix Blanche 10
CH-1630 Bulle
Switzerland
Name and address of the manufacturer(s) responsible for batch releaseUCB Pharma S.A.
Chemin du Foriest
B-1420 Braine l'Alleud
Belgium
Max shelf life
24 months
Storage conditions
2°C – 8°C
List of excipients
Sodium acetate
Sodium chloride
Water for injections

Support

Do you have a question about the product? Reach out to our team using the form below – we’d be happy to help you!

Ready to simplify your sourcing?

Here’s how to get started:

Select Your Licensed Molecules

Browse our shop and choose the licensed molecule(s) you need. Don’t worry if you can’t find the molecule you’re looking for – we can source it for you!

Get a Quote

Receive a confidential, non-binding quote for the molecule(s) you choose.

Get Qualified & We Deliver

Complete our quick qualification process, place your order, and we’ll ship your molecule(s) within days.

Do you have a question you'd like to ask us?

Here’s how to get started:

Reach out to our team - we'd be happy to help you!

Thank you for your interest in our services.

We will respond to you within one working day. You can now download your sample report.